![Michel Lagueux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michel Lagueux
Private Equity Investor at Gestion Bio Innovation, Inc.
Michel Lagueux active positions
Companies | Position | Start | End |
---|---|---|---|
Gestion Bio Innovation, Inc.
![]() Gestion Bio Innovation, Inc. Investment ManagersFinance Gestion Bio Innovation Inc (Gestion Bio Innovation) is a venture capital subsidiary of Centre Québécois de Valorisation des Biotechnologies founded in 1900. The firm is headquartered in Quebec, Canada. | Private Equity Investor | - | - |
Career history of Michel Lagueux
Former positions of Michel Lagueux
Companies | Position | Start | End |
---|---|---|---|
Akela Pharma, Inc.
![]() Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Director/Board Member | 28/06/2009 | 19/02/2010 |
BIOSYNTECH, INC. | Chairman | 22/07/2008 | 17/07/2009 |
President | 22/07/2008 | 17/07/2009 | |
Fonds de Solidarité FTQ
![]() Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Corporate Officer/Principal | 01/11/2006 | 01/05/2008 |
Innovatech Montreal, Inc.
![]() Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Head-Equity Investments | - | 30/06/2005 |
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Director/Board Member | - | - |
Multiple Capital, Inc.
![]() Multiple Capital, Inc. Investment ManagersFinance Founded in 2005, formerly Société Innovatech du Grand Montréal, Multiple Capital is a Montréal-based venture capital subsidiary of Collier Capital Ltd. | Corporate Officer/Principal | - | - |
Canacure Corp. | President | - | - |
Statistics
International
Canada | 8 |
United States | 2 |
Operational
President | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectoral
Finance | 5 |
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIOSYNTECH, INC. | Health Technology |
Private companies | 7 |
---|---|
Innovatech Montreal, Inc.
![]() Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Finance |
Fonds de Solidarité FTQ
![]() Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Finance |
Multiple Capital, Inc.
![]() Multiple Capital, Inc. Investment ManagersFinance Founded in 2005, formerly Société Innovatech du Grand Montréal, Multiple Capital is a Montréal-based venture capital subsidiary of Collier Capital Ltd. | Finance |
Akela Pharma, Inc.
![]() Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
Gestion Bio Innovation, Inc.
![]() Gestion Bio Innovation, Inc. Investment ManagersFinance Gestion Bio Innovation Inc (Gestion Bio Innovation) is a venture capital subsidiary of Centre Québécois de Valorisation des Biotechnologies founded in 1900. The firm is headquartered in Quebec, Canada. | Finance |
Canacure Corp. | |
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
- Stock Market
- Insiders
- Michel Lagueux
- Experience